Lionco Pharm Grp Co Ltd (603669) — Capital Reinvestment Ratio
Lionco Pharm Grp Co Ltd (603669) has a Capital Reinvestment Ratio of 0.68x as of September 2023, meaning it reinvests 1% of its operating cash flow (CN¥7.06 Million) in capital expenditures (CN¥4.78 Million). Check Lionco Pharm Grp Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Lionco Pharm Grp Co Ltd Capital Reinvestment Ratio (2011–2021)
This chart tracks Lionco Pharm Grp Co Ltd's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see 603669 cash flow metrics.
Annual Capital Reinvestment Ratio for Lionco Pharm Grp Co Ltd (2011–2021)
Year-by-year Capital Reinvestment Ratio for Lionco Pharm Grp Co Ltd from 2011 to 2021. See 603669 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.43x | CN¥128.50 Million | CN¥54.82 Million | ▼ -12.7% |
| 2020 | 0.49x | CN¥126.81 Million | CN¥61.95 Million | ▲ +959.1% |
| 2019 | 0.05x | CN¥235.61 Million | CN¥10.87 Million | ▼ -95.1% |
| 2018 | 0.93x | CN¥185.87 Million | CN¥173.70 Million | ▲ +104.0% |
| 2017 | 0.46x | CN¥189.01 Million | CN¥86.57 Million | ▼ -6.1% |
| 2016 | 0.49x | CN¥182.27 Million | CN¥88.94 Million | ▼ -31.2% |
| 2015 | 0.71x | CN¥98.88 Million | CN¥70.10 Million | ▲ +10.3% |
| 2014 | 0.64x | CN¥181.50 Million | CN¥116.70 Million | ▼ -0.6% |
| 2013 | 0.65x | CN¥160.77 Million | CN¥103.97 Million | ▼ -15.9% |
| 2012 | 0.77x | CN¥142.61 Million | CN¥109.64 Million | ▲ +205.3% |
| 2011 | 0.25x | CN¥98.23 Million | CN¥24.74 Million | — |